
|Articles|January 17, 2006
Urology Times BPA Statement, July 2005
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
4
Nicole L. Miller, MD, FACS, on assessing patients after BPH treatment failure
5











